The entire collaboration is overseen by a Joint Steering Committee co-chaired by GSK’s Head of Advanced Manufacturing Technologies Mark Buswell and the Head of Department of Chemical Engineering at Imperial, Andrew Livingston.  The project is managed by the two Oversight Managers Magalie Rocheville, External Engagement Lead at GSK, and Vjera Magdalenic-Moussavi, Imperial’s Corporate Partnership Manager for the Faculty of Medicine.